Novel avian influenza a (H7N9) virus induces impaired interferon responses in human dendritic cells

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Arilahti, Veera ^a   Mäkelä, Sanna M ^a   Tynell, Janne ^a   Julkunen, Ilkka ^a,b   Österlund, Pamela ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHAN1 INTERFERON; BETA INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON INDUCED TRANSMEMBRANE PROTEIN 3; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYXOVIRUS RESISTANCE PROTEIN A; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; CYTOKINE STORM; DENDRITIC CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N9; INNATE IMMUNITY; MONOCYTE DERIVED DENDRITIC CELL; PROTEIN EXPRESSION; VIRUS REPLICATION; VIRUS VIRULENCE; BIOSYNTHESIS; DRUG EFFECTS; IMMUNOLOGY; INFLUENZA A VIRUS (H7N9); VIROLOGY;

CYTOKINES; DENDRITIC CELLS; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INTERFERON-ALPHA; INTERFERON-BETA; VIRUS REPLICATION;

EID: 84900544523     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096350     Document Type: Article

References (47)

1. World Health Organization (2014) Number of conformed human cases of avian influenza (H7N9) reported to WHO. : http://www.who.int/influenza/human-animal- interface/influenza-h7n9/en/.
2. Gao HN, Lu HZ, Cao B, Du B, Shang H, et al. (2013) Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 368: 2277-2285. 10.1056/NEJMoa1305584.
3. Gao R, Cao B, Hu Y, Feng Z, Wang D, et al. (2013) Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368: 1888-1897. 10.1056/NEJMoa1304459.
4. Kageyama T, Fujisaki S, Takashita E, Xu H, Yamada S, et al. (2013) Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in china, february to april 2013. Euro Surveill 18: 20453.
5. Wu A, Su C, Wang D, Peng Y, Liu M, et al. (2013) Sequential reassortments underlie diverse influenza H7N9 genotypes in china. Cell Host Microbe 14: 446-452. 10.1016/j.chom.2013.09.001.
6. Lam TT, Wang J, Shen Y, Zhou B, Duan L, et al. (2013) The genesis and source of the H7N9 influenza viruses causing human infections in china. Nature 502: 241-244. 10.1038/nature12515.
7. Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, et al. (2013) Characterization of H7N9 influenza A viruses isolated from humans. Nature 501: 551-555. 10.1038/nature12392.
8. Zhou J, Wang D, Gao R, Zhao B, Song J, et al. (2013) Biological features of novel avian influenza A (H7N9) virus. Nature 499: 500-503. 10.1038/nature12379.
9. Shi Y, Zhang W, Wang F, Qi J, Wu Y, et al. (2013) Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science 342: 243-247. 10.1126/science.1242917.
10. Dortmans JC, Dekkers J, Wickramasinghe IN, Verheije MH, Rottier PJ, et al. (2013) Adaptation of novel H7N9 influenza A virus to human receptors. Sci Rep 3: 3058. 10.1038/srep03058.
11. Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, et al. (2013) Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341: 183-186. 10.1126/science.1239844.
12. Mok CK, Lee HH, Chan MC, Sia SF, Lestra M, et al. (2013) Pathogenicity of the novel A/H7N9 influenza virus in mice. MBio 4: 10.1128/mBio.00362-13.
13. Knepper J, Schierhorn KL, Becher A, Budt M, Tonnies M, et al. (2013) The novel human influenza A(H7N9) virus is naturally adapted to efficient growth in human lung tissue. MBio 4: 10.1128/mBio.00601-13.
14. Kreijtz JH, Kroeze EJ, Stittelaar KJ, de Waal L, van Amerongen G, et al. (2013) Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: A model to study intervention strategies. Vaccine 31: 4995-4999. 10.1016/j.vaccine.2013.06.071.
15. Richard M, Schrauwen EJ, de Graaf M, Bestebroer TM, Spronken MI, et al. (2013) Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature 501: 560-563. 10.1038/nature12476.
16. Xu L, Bao L, Deng W, Dong L, Zhu H, et al. (2013) The novel avian-origin human A (H7N9) influenza virus could be transmitted between ferrets via respiratory droplets. J Infect Dis. 10.1093/infdis/jit474.
17. Qi X, Qian YH, Bao CJ, Guo XL, Cui LB, et al. (2013) Probable person to person transmission of novel avian influenza A (H7N9) virus in eastern china, 2013: Epidemiological investigation. BMJ 347: f4752. 10.1136/bmj.f4752.
18. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203-7.
19. Osterlund P, Veckman V, Siren J, Klucher KM, Hiscott J, et al. (2005) Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J Virol 79: 9608-17. (Pubitemid 41022304)
20. Osterlund P, Pirhonen J, Ikonen N, Ronkko E, Strengell M, et al. (2010) Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol 84: 1414-22. JVI.01619-09 [pii] 10.1128/JVI.01619-09.
21. Osterlund P, Strengell M, Sarin LP, Poranen MM, Fagerlund R, et al. (2012) Incoming influenza A virus evades early host recognition, while influenza B virus induces interferon expression directly upon entry. J Virol 86: 11183-11193. 10.1128/JVI.01050-12.
22. Moltedo B, Lopez CB, Pazos M, Becker MI, Hermesh T, et al. (2009) Cutting edge: Stealth influenza virus replication precedes the initiation of adaptive immunity. J Immunol 183: 3569-73. jimmunol.0900091 [pii] 10.4049/jimmunol. 0900091.
23. Seo SH, Webby R, Webster RG (2004) No apoptotic deaths and different levels of inductions of inflammatory cytokines in alveolar macrophages infected with influenza viruses. Virology 329: 270-9. S0042-6822(04)00558-6 [pii] 10.1016/j.virol.2004.08.019.
24. Palucka K, Banchereau J. (2002) How dendritic cells and microbes interact to elicit or subvert protective immune responses. Curr Opin Immunol 14: 420-31. (Pubitemid 34671243)
25. Thitithanyanont A, Engering A, Ekchariyawat P, Wiboon-ut S, Limsalakpetch A, et al. (2007) High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands. J Immunol 179: 5220-5227.
26. Ronni T, Sareneva T, Pirhonen J, Julkunen I (1995) Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virusinfected human peripheral blood mononuclear cells. J Immunol 154: 2764-74.
27. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179: 1109-1118.
28. Ward CL, Dempsey MH, Ring CJ, Kempson RE, Zhang L, et al. (2004) Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement. J Clin Virol 29: 179-88. 10.1016/S1386-6532(03)00122- 7 S1386653203001227 [pii].
29. Melen K, Kinnunen L, Fagerlund R, Ikonen N, Twu KY, et al. (2007) Nuclear and nucleolar targeting of influenza A virus NS1 protein: Striking differences between different virus subtypes. J Virol 81: 5995-6006. (Pubitemid 46847036)
30. Matikainen S, Ronni T, Hurme M, Pine R, Julkunen I. (1996) Retinoic acid activates interferon regulatory factor-1 gene expression in myeloid cells. Blood 88: 114-23. (Pubitemid 26230678)
31. Ronni T, Melen K, Malygin A, Julkunen I (1993) Control of IFN-inducible MxA gene expression in human cells. J Immunol 150: 1715-26. (Pubitemid 23129647)
32. Osterlund PI, Pietila TE, Veckman V, Kotenko SV, Julkunen I (2007) IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J Immunol 179: 3434-42.
33. Jia D, Rahbar R, Chan RW, Lee SM, Chan MC, et al. (2010) Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling. PLoS One 5: e13927. 10.1371/journal.pone.0013927.
34. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, west nile virus, and dengue virus. Cell 139: 1243-1254. 10.1016/j.cell.2009.12.017.
35. Feeley EM, Sims JS, John SP, Chin CR, Pertel T, et al. (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7: e1002337. 10.1371/journal.ppat.1002337.
36. Everitt AR, Clare S, Pertel T, John SP, Wash RS, et al. (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484: 519-523. 10.1038/nature10921.
37. Wang Z, Zhang A, Wan Y, Liu X, Qiu C, et al. (2014) Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci U S A 111: 769-774. 10.1073/pnas.1321748111.
38. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, et al. (2009) Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A 106: 3455-60. 0813234106 [pii] 10.1073/pnas.0813234106.
39. Cilloniz C, Pantin-Jackwood MJ, Ni C, Goodman AG, Peng X, et al. (2010) Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection. J Virol 84: 7613-24. JVI.00553-10 [pii] 10.1128/JVI.00553-10.
40. Matthaei M, Budt M, Wolff T (2013) Highly pathogenic H5N1 influenza A virus strains provoke heterogeneous IFN-alpha/beta responses that distinctively affect viral propagation in human cells. PLoS One 8: e56659. 10.1371/journal.pone.0056659.
41. Ngunjiri JM, Mohni KN, Sekellick MJ, Schultz-Cherry S, Webster RG, et al. (2012) Lethal H5N1 influenza viruses are not resistant to interferon action in human, simian, porcine or chicken cells. Nat Med 18: 1456-1457. 10.1038/nm.2879.
42. Chi Y, Zhu Y, Wen T, Cui L, Ge Y, et al. (2013) Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in china. J Infect Dis. 10.1093/infdis/jit440.
43. Josset L, Zeng H, Kelly SM, Tumpey TM, Katze MG (2014) Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: Specific host response and responses intermediate between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options. MBio 5: e01102-13. 10.1128/mBio.01102-13.
44. Hale BG, Randall RE, Ortin J, Jackson D (2008) The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89: 2359-76. 89/10/2359 [pii] 10.1099/vir.0.2008/004606-0.
45. Cheung CY, Chan EY, Krasnoselsky A, Purdy D, Navare AT, et al. (2012) H5N1 virus causes significant perturbations in host proteome very early in influenza virus-infected primary human monocyte-derived macrophages. J Infect Dis 206: 640-645. 10.1093/infdis/jis423.
46. Pauli EK, Schmolke M, Wolff T, Viemann D, Roth J, et al. (2008) Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression. PLoS Pathog 4: e1000196. 10.1371/journal.ppat.1000196.
47. Shi J, Xie J, He Z, Hu Y, He Y, et al. (2013) A detailed epidemiological and clinical description of 6 human cases of avian-origin influenza A (H7N9) virus infection in shanghai. PLoS One 8: e77651. 10.1371/journal.pone.0077651.